C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity

Mol Immunol. 2009 Feb;46(5):991-8. doi: 10.1016/j.molimm.2008.09.034. Epub 2008 Nov 18.

Abstract

The fine regulation of NF-kappaB activity is crucial for both resting and stimulated cells and relies on complex balance between multiple activators and inhibitors. We report here that c-mip, a recently identified pleckstrin homology (PH) and leucine-rich repeat (LRR)-domain-containing protein, inactivates GSKbeta and interacts with RelA, a key member of the NF-kappaB family. We show that c-mip inhibits the degradation of I-kappaBalpha and impedes the dissociation of the NF-kappaB/I-kappaBalpha complexes. C-mip acts downstream signaling of classical NF-kappaB pathway and may represent one of the missing links in the control of NF-kappaB activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins / immunology*
  • Carrier Proteins / metabolism
  • Glycogen Synthase Kinase 3 / immunology*
  • Glycogen Synthase Kinase 3 / metabolism
  • Glycogen Synthase Kinase 3 beta
  • Humans
  • I-kappa B Proteins / immunology*
  • I-kappa B Proteins / metabolism
  • Leukocytes, Mononuclear / cytology
  • Leukocytes, Mononuclear / immunology*
  • Leukocytes, Mononuclear / metabolism
  • NF-KappaB Inhibitor alpha
  • Protein Structure, Tertiary / physiology
  • Signal Transduction / immunology*
  • Transcription Factor RelA / immunology*
  • Transcription Factor RelA / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • CMIP protein, human
  • Carrier Proteins
  • I-kappa B Proteins
  • NFKBIA protein, human
  • RELA protein, human
  • Transcription Factor RelA
  • NF-KappaB Inhibitor alpha
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3